BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33233470)

  • 1. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.
    Creeden JF; Alganem K; Imami AS; Henkel ND; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.
    Creeden JF; Alganem K; Imami AS; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
    Trible RP; Emert-Sedlak L; Smithgall TE
    J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis.
    Poh AR; O'Brien M; Chisanga D; He H; Baloyan D; Traichel J; Dijkstra C; Chopin M; Nutt S; Whitehead L; Boon L; Parkin A; Lowell C; Pajic M; Shi W; Nikfarjam M; Ernst M
    Cell Rep; 2022 Oct; 41(2):111479. PubMed ID: 36223746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
    Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR
    J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
    Montero JC; Seoane S; Ocaña A; Pandiella A
    Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of src-related tyrosine kinases by IL-3.
    Anderson SM; Jorgensen B
    J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
    Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
    J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
    Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
    Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.
    Kubo T; Kuroda Y; Kokubu A; Hosoda F; Arai Y; Hiraoka N; Hirohashi S; Shibata T
    Pancreas; 2009 Oct; 38(7):e200-6. PubMed ID: 19893451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo.
    Briggs SD; Lerner EC; Smithgall TE
    Biochemistry; 2000 Jan; 39(3):489-95. PubMed ID: 10642173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
    Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
    Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH2 domains of Src family kinases associate with Syk.
    Aoki Y; Kim YT; Stillwell R; Kim TJ; Pillai S
    J Biol Chem; 1995 Jun; 270(26):15658-63. PubMed ID: 7797565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.